Ambulatory Management of Worsening Heart Failure: Current Strategies and Future Directions

被引:4
|
作者
Wand, Alison L. [1 ]
Russell, Stuart D. [2 ]
Gilotra, Nisha A. [1 ]
机构
[1] Johns Hopkins Univ, Dept Med, Div Cardiol, Sch Med, 600 N Wolfe St,Carnegie Suite 568, Baltimore, MD 21287 USA
[2] Duke Univ, Dept Med, Div Cardiol, Sch Med, Durham, NC USA
来源
HEART INTERNATIONAL | 2021年 / 15卷 / 01期
关键词
Heart failure; worsening heart failure; ambulatory treatment; outpatient treatment; remote monitoring; telemonitoring; intravenous diuretics; subcutaneous diuretics; INTRAVENOUS DIURETIC THERAPY; SUBCUTANEOUS FUROSEMIDE; LOOP DIURETICS; CARE; COVID-19; IMPACT; HOSPITALIZATION; MORTALITY; OUTCOMES; ALGORITHM;
D O I
10.17925/HI.2021.15.1.49
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) is a highly prevalent and morbid disease in the USA. The chronic, progressive course of HF is defined by periodic exacerbations of symptoms, described as 'worsening heart failure' (WHF). Previously, episodes of WHF have required hospitalization for intravenous diuretics; however, recent innovations in care delivery models for patients with HF have allowed a transition from the acute care setting to the ambulatory setting. The development of remote monitoring strategies, including device-based algorithms and implantable haemodynamic monitoring systems, has facilitated more advanced surveillance of patients, aiming to prevent the clinical deterioration that leads to hospitalization. Additionally, the establishment of multidisciplinary HF clinics has provided the setting and resources for the outpatient treatment of WHF, specifically the administration of intravenous diuretics. Here we review the current state of ambulatory HF management, including mechanisms for patient monitoring and treatment, and outline future opportunities for outpatient management of this patient population.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [21] Exercise Training as Therapy for Heart Failure Current Status and Future Directions
    Fleg, Jerome L.
    Cooper, Lawton S.
    Borlaug, Barry A.
    Haykowsky, Mark J.
    Kraus, William E.
    Levine, Benjamin D.
    Pfeffer, Marc A.
    Pina, Ileana L.
    Poole, David C.
    Reeves, Gordon R.
    Whellan, David J.
    Kitzman, Dalane W.
    CIRCULATION-HEART FAILURE, 2015, 8 (01) : 209 - 220
  • [22] Racial and ethnic disparities in heart failure: current state and future directions
    Lewsey, Sabra C.
    Breathett, Khadijah
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (03) : 320 - 328
  • [23] Atrial Fibrillation in Patients with Heart Failure: Current State and Future Directions
    Tuoyo O. Mene-Afejuku
    Persio D. López
    Adedoyin Akinlonu
    Carissa Dumancas
    Ferdinand Visco
    Savi Mushiyev
    Gerald Pekler
    American Journal of Cardiovascular Drugs, 2018, 18 : 347 - 360
  • [24] Obstructive Sleep Apnea in Heart Failure: Current Knowledge and Future Directions
    Javaheri, Shahrokh
    Javaheri, Sogol
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [25] Current Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure
    Ahmad, Yousif
    Lansky, Alexandra J.
    Velazquez, Eric J.
    JAMA CARDIOLOGY, 2022, 7 (06) : 577 - 578
  • [26] Chronic Heart Failure Current Evidence, Challenges to Therapy, and Future Directions
    Morrissey, Ryan P.
    Czer, Lawrence
    Shah, Prediman K.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2011, 11 (03) : 153 - 171
  • [27] Endothelin receptor antagonists in heart failure - Current status and future directions
    Ertl, G
    Bauersachs, J
    DRUGS, 2004, 64 (10) : 1029 - 1040
  • [28] Atrial Fibrillation in Patients with Heart Failure: Current State and Future Directions
    Mene-Afejuku, Tuoyo O.
    Lopez, Persio D.
    Akinlonu, Adedoyin
    Dumancas, Carissa
    Visco, Ferdinand
    Mushiyev, Savi
    Pekler, Gerald
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (05) : 347 - 360
  • [29] Settling the IRONy of Anemia in Heart Failure: Current Evidence and Future Directions
    Tsangaris, Adamantios
    Ambrosy, Andrew P.
    Tschida, Michael
    Alexy, Tamas
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (05) : 691 - 693
  • [30] Management Of Worsening Heart Failure With Subcutaneous Furosemide In A High-risk Ambulatory Patient Cohort
    Patel, Hamza
    Riley, Sarah
    Dorsey, Elissa
    Chambers, Julianne
    Barkdoll, Jessica
    Xie, Michelle m
    Babola, Natalie
    Thomas, Kamishia
    Awuah-asamoah, Ama
    Henry, Leeann
    Heisler, Kara
    Cuomo, Kimberly
    Gilotra, Nisha
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)